Ep. 85: Value of Digital Therapeutics – Jhonatan Dimitriades, MD (CEO Lapsi Health)

Health Unchained

Ep. 85: Value of Digital Therapeutics – Jhonatan Dimitriades, MD (CEO Lapsi Health)

Jhonatan Bringas Dimitriades, MD is an executive …
August 21, 2021

Ep. 85: Value of Digital Therapeutics – Jhonatan Dimitriades, MD (CEO Lapsi Health)

Jhonatan Bringas Dimitriades, MD is an executive who works with technologists, developers, medical professionals and patients to deliver the right digital and technical solutions to enhance the diagnosis, treatment, recovery and quality of life of patients around the globe.

Personal Website:
Company Website:

Dr. Bringas has worked in the implementation of medical technologies in some of the top medical centers worldwide, such as the Mayo Clinic, the Cleveland Clinic, the Panama Clinic, the Hong Kong University Hospital, the AMC UMC Amsterdam and many others. His work is related to medical implementation of technologies, digital health, and innovation in the medical devices area.

Jhonatan is a certified Occupational Physician, with postgraduate education in Public Health, Business Strategy and Digital Healthcare solutions. Jhonatan holds a Medical Degree, re-certified in 3 continents and has held the positions of Medical Director, Chief Medical Officer and is currently the Chief Communications Officer of Finnish MedTech NUKUTE, a respiratory / sleep medicine wearable company and the Chief Medical Officer of American DTX startup DiaM Life, in the Diabetes Mellitus space.

He is co-founder and CEO of Lapsi Health, an early stage startup developing digital therapeutics starting with solutions for chronic asthma pediatric patients. We talked about the evolution of digital therapeutics and wearables from a medical doctor’s perspective. Although this episode is light on blockchain talk, it was a great conversation about the future of digital health and how we can get there.

Show topics
•Jhonatan’s background
•Lapsi Health
•Digital Therapeutics
•Clinical Trials
•Doctor’s perspective

News Corner

ConsenSys Health to Acquire FHIRBlocks to Enable Patients to Exercise Fine-Grained Control of Their Confidential Healthcare Information

On August 10, 2021, ConsenSys Health agreed to acquire FHIRBlocks, an innovative developer of solutions to support self-sovereign patient-directed fine-grained sharing of protected personal health information. The acquisition includes the transfer of FHIRBlocks’ Intellectual Property, as well as key executives and staff, business activities and relationships, to ConsenSys Health.
Currently, slow and error-prone manual processes have largely been used to administer patient data consents, but the introduction of digital communications using Fast Healthcare Interoperability Resources (FHIR) for data-interoperability has shown clear benefits and is now mandated by regulations, such as the U.S. 21st Century Cures Act. In addition, patient and consumer privacy regulations, such as HIPAA, GDPR and CCPA are also mandating new processes.

Health Unchained Links

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

Y’all Means All Communities are powered by people—and the variety of lives, jobs, schedules, and skills keep cities buzzing. Providing care means healthcare has to show up for "y’all" no matter the gender identity, work schedule, or preferred language.